Rena Yadlapati1, Christopher Adkins2, Diana-Marie Jaiyeola2, Alcina K Lidder3, Andrew J Gawron4, Bruce K Tan5, Nadine Shabeeb6, Caroline P E Price5, Neelima Agrawal5, Michael Ellenbogen2, Stephanie S Smith5, Michiel Bove5, John E Pandolfino2. 1. Division of Gastroenterology and Hepatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. Electronic address: rena.yadlapati@northwestern.edu. 2. Division of Gastroenterology and Hepatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 3. University of Rochester School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, New York. 4. Division of Gastroenterology, University of Utah, Salt Lake City, Utah. 5. Division of Otolaryngology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 6. University of Indiana School of Medicine, Indianapolis, Indiana.
Abstract
BACKGROUND & AIMS: It has been a challenge to confirm the association between laryngeal symptoms and physiological reflux disease. We examined the ability of oropharyngeal pH tests (with the Restech Dx-pH system) and salivary pepsin tests (with Peptest) to discriminate between asymptomatic volunteers (controls) and subjects with a combination of laryngeal and reflux symptoms (laryngeal ± reflux). METHODS: We performed a physician-blinded prospective cohort study of 59 subjects at a single academic institution. Adult volunteers were recruited and separated into 3 groups on the basis of GerdQ and Reflux Symptom Index scores: controls (n = 20), laryngeal symptoms (n = 20), or laryngeal + reflux symptoms (n = 19). Subjects underwent laryngoscopy and oropharyngeal pH tests and submitted saliva samples for analysis of pepsin concentration. Primary outcomes included abnormal acid exposure and composite (RYAN) score for oropharyngeal pH tests and abnormal mean salivary pepsin concentration that was based on normative data. RESULTS: Complete oropharyngeal pH data were available from 53 subjects and complete salivary pepsin data from 35 subjects. We did not observe any significant differences between groups in percent of time spent below pH 4.0, 5.0, 5.5, 6.0, or RYAN scores or percent of subjects with positive results from tests for salivary pepsin (53% vs 40% vs 75%; P = .50, respectively). The laryngeal + reflux group had a significantly higher estimated mean concentration of salivary pepsin (117.9 ± 147.4 ng/mL) than the control group (32.4 ± 41.9 ng/mL) or laryngeal symptom group (7.5 ± 11.2 ng/mL) (P = .01 and P = .04, respectively). CONCLUSIONS: By using current normative thresholds, oropharyngeal pH testing and salivary pepsin analysis are not able to distinguish between healthy volunteers and subjects with a combination of laryngeal and reflux symptoms.
BACKGROUND & AIMS: It has been a challenge to confirm the association between laryngeal symptoms and physiological reflux disease. We examined the ability of oropharyngeal pH tests (with the Restech Dx-pH system) and salivary pepsin tests (with Peptest) to discriminate between asymptomatic volunteers (controls) and subjects with a combination of laryngeal and reflux symptoms (laryngeal ± reflux). METHODS: We performed a physician-blinded prospective cohort study of 59 subjects at a single academic institution. Adult volunteers were recruited and separated into 3 groups on the basis of GerdQ and Reflux Symptom Index scores: controls (n = 20), laryngeal symptoms (n = 20), or laryngeal + reflux symptoms (n = 19). Subjects underwent laryngoscopy and oropharyngeal pH tests and submitted saliva samples for analysis of pepsin concentration. Primary outcomes included abnormal acid exposure and composite (RYAN) score for oropharyngeal pH tests and abnormal mean salivary pepsin concentration that was based on normative data. RESULTS: Complete oropharyngeal pH data were available from 53 subjects and complete salivary pepsin data from 35 subjects. We did not observe any significant differences between groups in percent of time spent below pH 4.0, 5.0, 5.5, 6.0, or RYAN scores or percent of subjects with positive results from tests for salivary pepsin (53% vs 40% vs 75%; P = .50, respectively). The laryngeal + reflux group had a significantly higher estimated mean concentration of salivary pepsin (117.9 ± 147.4 ng/mL) than the control group (32.4 ± 41.9 ng/mL) or laryngeal symptom group (7.5 ± 11.2 ng/mL) (P = .01 and P = .04, respectively). CONCLUSIONS: By using current normative thresholds, oropharyngeal pH testing and salivary pepsin analysis are not able to distinguish between healthy volunteers and subjects with a combination of laryngeal and reflux symptoms.
Authors: Michael Friedman; Alexander Maley; Kanwar Kelley; Tanya Pulver; Michael Foster; Michelle Fisher; Ninos Joseph Journal: Otolaryngol Head Neck Surg Date: 2011-02-14 Impact factor: 3.497
Authors: S Ayazi; J C Lipham; J A Hagen; A L Tang; J Zehetner; J M Leers; A Oezcelik; E Abate; F Banki; S R DeMeester; T R DeMeester Journal: J Gastrointest Surg Date: 2009-05-07 Impact factor: 3.452
Authors: George Sun; Srikant Muddana; James C Slaughter; Sean Casey; Eric Hill; Farnoosh Farrokhi; C Gaelyn Garrett; Michael F Vaezi Journal: Laryngoscope Date: 2009-08 Impact factor: 3.325
Authors: Claudio F Milstein; Samer Charbel; Douglas M Hicks; Tom I Abelson; Joel E Richter; Michael F Vaezi Journal: Laryngoscope Date: 2005-12 Impact factor: 3.325
Authors: Elif Saritas Yuksel; Shih-Kuang S Hong; Vicki Strugala; James C Slaughter; Marion Goutte; C Gaelyn Garrett; Peter W Dettmar; Michael F Vaezi Journal: Laryngoscope Date: 2012-03-23 Impact factor: 3.325
Authors: Philip O Katz; Kerry B Dunbar; Felice H Schnoll-Sussman; Katarina B Greer; Rena Yadlapati; Stuart Jon Spechler Journal: Am J Gastroenterol Date: 2022-01-01 Impact factor: 10.864
Authors: Rena Yadlapati; John E Pandolfino; Alcina K Lidder; Nadine Shabeeb; Diana-Marie Jaiyeola; Christopher Adkins; Neelima Agrawal; Andrew Cooper; Caroline P E Price; Jody D Ciolino; Andrew J Gawron; Stephanie S Smith; Michiel Bove; Bruce K Tan Journal: Am J Gastroenterol Date: 2016-04-19 Impact factor: 10.864